Naka et al. suggested that SS was a stem cell malignancy caused by the SS18-SSX fusion protein as it had the capacity for self-renewal and multi-lineage differentiation, which had the ability to induce EMT [2, 3]. The gene discussed is SS18; the disease is synovial sarcoma.